KAN-0438757

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NameKAN-0438757
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 inhibitors
Targets6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3
Therapy Area/IndicationsPancreatic NeoplasmsColorectal NeoplasmsBreast Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKancera
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKancera
Active IndicationsN/A
Inactive IndicationsPancreatic NeoplasmsColorectal NeoplasmsBreast Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A